North Carolina’s eugenic past makes headlines again
North Carolina’s eugenic past has made headlines again as legislators push to compensate the estimated 7,600 victims of its eugenics program. This ran between 1933...
Do we need to rename “persistent vegetative state”?
Do we need to change the name of persistent vegetative state? Do we need to change the name of persistent vegetative state? A feature in...
Massachusetts Medical Society reasserts opposition to physician-assisted suicide
The 23,000 members of the Massachusetts Medical Society have voted against physician-assisted suicide. Its House of Delegates voted by a large majority for maintaining a...
Cloning in Korea
The recent past of Korea’s cloning research is best described as dubious. Disgraced Seoul University professor Hwang Woo-suk claimed in 2004 to have cloned human...
Many surrogate children end up in legal limbo
In a story that contrasts with the optimistic surrogacy story in BioEdge last week, at least 15 children born to Irish couples who used overseas...
Drug wakes those who are near death
A gripping feature about the mysteries of the human brain and parental love appeared in the New York Times recently. A gripping feature about the...
Swedish academic argues for triparenting
One parent is good. Two parents are better. Three parents might be better still. So argues a researcher from Sweden, who published a paper in...
Court will hear IVF benefits
The US Supreme Court will hear a case about whether children conceived through IVF after the death of a parent are eligible for Social Security...
US mothers participate in clinical trials to make ends meet
More cash-strapped mums are signing up for clinical trials. More cash-strapped mums are signing up for clinical trials. Yvette Santana, a 37-year-old mother of 4...
One in five IVF procedures are in women over 40
More older women than ever are using IVF in the UK. More older women than ever are using IVF in the UK. New figures from...
Questions over clinical trials in India
Western pharmaceutical companies have pinpointed India as a prime candidate for outsourcing clinical trials, due to its population and lax regulations, which help slash research...
Marketing and science clash in Gardasil debate
Gardasil, Merck’s vaccine against the human papilloma virus, the most common sexually transmitted disease, is once again at the centre of political, moral, bioethical and...